SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.85+0.2%Dec 12 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: The Perfect Hedge who wrote ()4/20/1998 11:45:00 AM
From: Nick  Read Replies (1) of 9523
 
RESEARCH ALERT - PaineWebber ups Pfizer
NEW YORK, April 20 (Reuters) - PaineWebber said on Monday it raised its rating on shares of Pfizer Inc. to attractive from neutral.
-- Viagra, Pfizer's new drug for erectile dysfunction, had new prescriptions of 36,263 for the week ended April 10.

-- Analyst Jeff Chaffkin said this was the largest first week launch in history.

-- ''While we expect this drug to have an unusually steep ramp-up, then a more gradual rise, this initial level is clearly higher than our expectations and a sign of tremendous pent-up demand,'' he said.

-- Biggest long-term issue will be whether growth can be sustained but preliminary signs are encouraging, he said.

--------------------------------------------------------------------------------
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext